MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Effects of zonisamide on parkinsonism in patients with dementia with Lewy bodies by severity of cognitive dysfunction and BPSD: subgroup analysis of pooled data from two trials

    K. Hasegawa, J. Goldman, T. Odawara, K. Kochi, O. Konishi, H. Maruyama, S. Toya, K. Kosaka, M. Murata, I. Mckeith (Kanagawa, Japan)

    Objective: To characterize the efficacy and safety of zonisamide (ZNS) in patients with dementia with Lewy bodies (DLB) with parkinsonism, we performed subgroup analysis by…
  • 2019 International Congress

    Efficacy and Safety of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder in Parkinson’s Disease.

    M. Meloni, M. Figorilli, M. Carta, L. Tamburrino, A. Cannas, M. Fantini, G. Defazio, M. Puligheddu (Cagliari, Italy)

    Objective: To evaluate the efficacy of the 5-HTP on RBD status in patients with Parkinson's disease (PD). Background: REM sleep behavior disorder (RBD) is reported…
  • 2019 International Congress

    A phase IIa trial studying the safety and tolerability of IRL752 in patients with Parkinson’s disease dementia

    P. Svenningsson, P. Odin, N. Dizdar, F. Bergquist, A. Johansson, D. Nyholm, K. Wictorin, J. Tedroff (Uppsala, Sweden)

    Objective: The primary objective was to investigate the safety and tolerability of IRL752 in PD patients with dementia in a randomized controlled trial. Secondary outcome…
  • 2019 International Congress

    The role of dysfunctional attentional processing in isolated minor hallucinations in Parkinson’s disease

    H. Bejr-Kasem, J. Pagonabarraga, S. Martínez-Horta, F. Ruiz-Martínez, F. Bernasconi, F. Sampedro, J. Marín-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, B. Pascual-Sedano, O. Blanke, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore attentional processing deficits in Parkinson's disease (PD) with minor hallucinations using a selective visual attention task. Background: Recent literature points to a…
  • 2019 International Congress

    Using whole genome sequencing and intronic sequence analysis to identify pathogenic variants in Parkin-related Parkinson’s Disease

    R. Davis, K. Kumar, F. Edema-Hildebrand, J-S. Park, B. Koentjoro, V. Gayevskiy, M. Cowley, N. Blair, C. Sue (St Leonards, Australia)

    Objective: To clarify the genetic cause of autosomal recessive early-onset Parkinson’s Disease (EOPD) for which only a single heterozygous coding mutation could be identified. Background:…
  • 2019 International Congress

    Fragile X syndrome presenting with levodopa unresponsive parkinsonism

    J. Mayer, J. Panicker, S. Alusi (Liverpool, United Kingdom)

    Objective: To describe a case of genetically confirmed Fragile X syndrome presenting with levodopa unresponsive Parkinsonism Background: Parkinsonism with or without ataxia is well recognised…
  • 2019 International Congress

    A family of Phospholipase A2-associated neurodegeneration presented as complicated hereditary spastic paraplegia

    MC. Wu, MY. Lan, JW. Li, YF. Chen, YY. Chang (Kaohsiung, Taiwan)

    Objective: To present reported two siblings of PLAN representing complicated HSP. Background: Neurodegeneration with brain iron accumulation (NBIA) is a group of diseases characterized by…
  • 2019 International Congress

    Biomarkers of idiopathic REM sleep behavior disorder versus RBD within narcolepsy

    E. Antelmi, F. Pizza, Y. Sosero, V. Donadio, A. Incensi, R. Liguori, G. Plazzi (Bologna, Italy)

    Objective: We compared iRBD versus secondary RBD due to narcolepsy, searching for discriminating clinical, neurophysiological and pathological biomarkers. Background: Idiopathic REM sleep behavior disorder (iRBD)…
  • 2019 International Congress

    “So much easier”; patient’s perceptions of Virtual Clinics for Parkinson’s Disease

    L. Evans, B. Mohamed, EC. Thomas (Cardiff, United Kingdom)

    Objective: Our virtual clinic for People with Parkinson’s disease (PwP) is a service innovation, providing a consultation with a Parkinson’s clinic doctor via telephone, with…
  • 2019 International Congress

    Understanding the Needs and Concerns of Newly Diagnosed People with Parkinson’s Disease

    V. Todaro, M. Feeney, A. Diaz, S. Rosenfeld, J. Gannon (New York, NY, USA)

    Objective: To identify the concerns of those newly diagnosed with Parkinson’s (up to three years since diagnosis) through an online survey and utilize findings to inform…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley